ArticleFrontiers in oncology2023

Pembrolizumab plus lenvatinib in advanced endometrial cancer: case report and systematic review of lung toxicity.

Nicoletta Staropoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.